P. Devereaux

Statistics and Probability · 2002–2017

A researcher in the Science corpus: 13 papers; trusts 10 researchers and is trusted by 7 researchers here, as inferred from the citation graph.

Subfields

• Statistics and Probability — 180 citations into it; #5,931 of 12,932 by trust here, #128 by citations
• Economics and Econometrics — 70 citations into it; #12,339 of 23,481 by trust here, #2,568 by citations
• General Health Professions — 50 citations into it; #2,599 of 4,781 by trust here, #43 by citations
• Public Health, Environmental and Occupational Health — 40 citations into it; #798 of 2,368 by trust here, #126 by citations

Whom P. Devereaux trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. Julian P. T. Higgins
2. David Moher
3. Douglas G. Altman
4. Sander Greenland
5. John P. A. Ioannidis

Who trusts P. Devereaux overall

1. K. F. Schulz
2. Douglas G. Altman
3. David Moher
4. J. Wetterslev
5. J. Brok

Papers from P. Devereaux's perspective

Ordered by how strongly the researchers P. Devereaux trusts endorse each paper. Same corpus, a different order for every researcher.

1. Systematic Review and Meta-analysis Supplements for Primary and Secondary Prevention: Mortality in Randomized Trials of Antioxidant
2. Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review (Medical Journal of Australia)
3. Network meta‐analysis for indirect treatment comparisons (Statistics in Medicine)
4. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. (The Lancet)
5. Vasopressin versus norepinephrine infusion in patients with septic shock. (New England Journal of Medicine)
6. Principles of multilevel modelling. (International Journal of Epidemiology)
7. Optimal medical therapy with or without PCI for stable coronary disease. (New England Journal of Medicine)
8. What is missing from descriptions of treatment in trials and reviews? (British medical journal)
9. Statistical considerations in the intent-to-treat principle. (Controlled Clinical Trials)
10. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. (New England Journal of Medicine)

Their papers

• CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials (2010) — 6,841 citations
• The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration (2009) — 37,422 citations
• CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. (2012) — 3,604 citations
• The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration (2009) — 15,061 citations
• Randomized trials stopped early for benefit: a systematic review. (2005) — 724 citations
• GRADE guidelines 6. Rating the quality of evidence--imprecision. (2011) — 2,352 citations
• Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses? (2009) — 758 citations
• Discrimination and Calibration of Clinical Prediction Models: Users’ Guides to the Medical Literature (2017) — 1,369 citations
• An introduction to multiplicity issues in clinical trials: the what, why, when and how. (2016) — 385 citations
• Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement (2014) — 11,185 citations
• Effect of early surgery after hip fracture on mortality and complications: systematic review and meta-analysis (2010) — 901 citations
• Internal fixation compared with arthroplasty for displaced fractures of the femoral neck. A meta-analysis. (2003) — 628 citations
• Clinical expertise in the era of evidence-based medicine and patient choice (2002) — 621 citations